Poster Session 1-3 AML: Chromosomal and genetic mutations

Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Keisuke Kataoka (Division of Moleculor Oncology, National Cancer Center Researchinstitute)

+Add all to schedule

[PS1-3-1] Expression level of cytokines in patients with AML patients with wild-type FLT3 and mutant FLT3

Renbin Zhao, Xin Guan, Lili Gao, Zefeng Yang (Hematology department of the first people's hospital of yunnan province, Kunming, People's Republic of China)

[PS1-3-2] Expression of a novel ZMYND11/MBTD1 fusion transcript in CD7+CD56+ AML with t(10;17)(p15;q21)

Katsuya Yamamoto¹, Kimikazu Yakushijin¹, Hiroya Ichikawa¹, Seiji Kakiuchi¹, Shinichiro Kawamoto¹, Hisayuki Matsumoto², Yuji Nakamachi², Jun Saegusa², Hiroshi Matsuoka¹, Hironobu Minami¹ (1.Department of Medical Oncology/Hematology, Kobe University, Kobe, Japan, 2.Department of Clinical Laboratory, Kobe University, Kobe, Japan)

[PS1-3-3] Trisomy 6 as the sole stemline abnormality in a patient with acute monocytic leukemia: a case report

Masahiro Manabe¹, Reiko Asada², Yuji Hagiwara², Dai Momose¹, Yasuyoshi Sugano¹, Takeshi Mazaki³, Ki-Ryang Koh¹ (1.Hematology, Osaka General Hospital of West Japan Railway Company, 2.Clinical Laboratory, Osaka General Hospital of West Japan Railway Company, 3.Pathology, Osaka General Hospital of West Japan Railway Company)

[PS1-3-4] NPM1, CEBPA and FLT3-ITD/TKD gene mutations in acute myelogenous leukemia

Shano Naseem¹, Varma Neelam¹, Jogeshwar Binota¹, Harpreet Virk¹, Pankaj Malhotra², Subhash Varma² (1.Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, Republic of India, 2.Department of Internal Medecine, Postgraduate Institute of Medical Education and Research, Chandigarh, Republic of India)

[PS1-3-5] Two cases of acute myeloid leukemia that FLT3-ITD became false-negative in standard PCR method

Masahiro Sakaguchi¹, Hiroki Yamaguchi¹, Yuho Najima², Katsuhiro Shono^1,3, Daishi Onai¹, Atsushi Marumo¹, Ikuko Omori¹, Satoshi Yamanaka¹, Yusuke Fujiwara¹, Shunsuke Yui¹, Masahiro Okabe¹, Satoshi Wakita¹, Muneo Okamoto¹, Kunihito Arai¹, Tomoaki Kitano¹, Kazuteru Ohashi², Koiti Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan)

[PS1-3-6] Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia

Seiji Kakiuchi¹, Rina Sakai², Koji Kawaguchi², Ako Higashime², Keiji Kurata², Hiroya Ichikawa², Shigeki Nagao³, Junpei Rikitake¹, Naomi Kiyota², Kimikazu Yakushijin², Hiroshi Matsuoka², Hironobu Minami² (1.Department of Hematology, Yodogawa Christian Hospital, Osaka, Japan., 2.Department of Medical Oncology/Hematology, Kobe University Hospital, Kobe, Japan, 3.Division of Hematology, National Defense Medical College Hospital, Tokorozawa, Japan)

[PS1-3-7] Two cases of AML with ectopic gene expression resulting from the ETV6 rearrangements

Akihiro Abe¹, Yukiya Yamamoto¹, Akinao Okamoto¹, Chisako Iriyama¹, Masutaka Tokuda¹, Yoko Inaguma¹, Tadaharu Kanie¹, Akihiro Tomita¹, Yoshiki Akatsuka¹, Masataka Okamoto¹, Toshiki Kameyama², Akila Mayeda², Nobuhiko Emi¹ (1.Dept. Hemat., Fujita Health Univ., Toyoake, Japan, 2.Div. Gene Exp. Mech., ICMS, Fujita Health Univ., Toyoake, Japan)